US Stock MarketDetailed Quotes
JAGX Jaguar Health
- 0.9255
- +0.0524+6.00%
Close Dec 20 16:00 ET
- 0.9510
- +0.0255+2.76%
Post 20:01 ET
10.92MMarket Cap-0.26P/E (TTM)
0.9751High0.8800Low529.16KVolume0.8975Open0.8731Pre Close490.39KTurnover4.97%Turnover RatioLossP/E (Static)11.80MShares21.600052wk High0.80P/B9.86MFloat Cap0.843552wk Low--Dividend TTM10.66MShs Float100075500.0000Historical High--Div YieldTTM10.89%Amplitude0.8430Historical Low0.9260Avg Price1Lot Size
Jaguar Health Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 6.61%-6.34M | 9.78%-8.17M | 29.14%-7.05M | -0.42%-33.24M | -16.00%-7.45M | 20.39%-6.79M | 13.40%-9.06M | -29.24%-9.95M | 5.34%-33.1M | 28.02%-6.42M |
| Net income from continuing operations | -27.52%-10.19M | 19.71%-9.72M | 27.54%-9.15M | 14.68%-41.87M | -2.63%-9.15M | 36.66%-7.99M | -28.95%-12.11M | 30.47%-12.63M | 6.70%-49.08M | 37.76%-8.91M |
| Operating gains losses | 100.87%32K | 400.00%30K | -4,064.52%-1.23M | -266.71%-3.65M | 1,000.00%9K | -369,300.00%-3.69M | 100.96%6K | -98.90%31K | -10.22%2.19M | ---1K |
| Depreciation and amortization | -4.64%596K | -9.98%559K | 10.71%610K | 4.19%2.39M | -1.83%591K | 6.47%625K | -4.17%621K | 21.10%551K | 26.42%2.29M | 25.94%602K |
| Other non cash items | --0 | -99.71%9K | -81.00%274K | 6.33%13.38M | -45.31%1.72M | 124.06%7.09M | 10.36%3.13M | -58.12%1.44M | 142.55%12.58M | 103.90%3.14M |
| Change In working capital | 96.82%-178K | 37.91%-1.24M | 14.53%-153K | -150.65%-11.1M | -43.51%-3.33M | -2,221.58%-5.6M | 53.86%-2M | -107.28%-179K | -295.32%-4.43M | -220.59%-2.32M |
| -Change in receivables | 121.62%64K | 411.61%349K | -54.85%465K | 170.78%298K | -1,145.16%-324K | 28.16%-296K | -168.71%-112K | 607.39%1.03M | -117.43%-421K | -49.18%31K |
| -Change in inventory | -2.61%-118K | -227.62%-536K | 110.18%169K | -1.93%-2.17M | -91.49%-810K | -179.86%-115K | 122.50%420K | -7,645.45%-1.66M | -0.28%-2.12M | -9.30%-423K |
| -Change in prepaid assets | -17.64%962K | 57.86%-1.53M | -610.00%-1.14M | -221.22%-5.01M | -668.81%-2.39M | 2,079.66%1.17M | -113.79%-3.63M | -131.56%-160K | -95.98%-1.56M | -154.28%-311K |
| -Change in payables and accrued expense | 102.30%143K | -56.48%628K | -265.54%-1.13M | -802.95%-3.81M | 112.22%288K | -2,475.19%-6.22M | 207.68%1.44M | -68.54%682K | -83.02%542K | -208.32%-2.36M |
| -Change in other current assets | -26,575.00%-1.07M | -50.00%1K | 4,183.33%735K | 96.91%-17K | -99.64%3K | 95.51%-4K | 100.15%2K | -260.00%-18K | -34.80%-550K | 289.89%845K |
| -Change in other current liabilities | 4.80%-119K | 9.02%-111K | -101.89%-107K | -25.08%-394K | 9.62%-94K | -43.68%-125K | -28.42%-122K | -82.76%-53K | -1,557.89%-315K | -89.09%-104K |
| -Change in other working capital | ---43K | ---42K | --850K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 6.61%-6.34M | 9.78%-8.17M | 29.14%-7.05M | -0.42%-33.24M | -16.00%-7.45M | 20.39%-6.79M | 13.40%-9.06M | -29.24%-9.95M | 5.34%-33.1M | 28.02%-6.42M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | -27,816.67%-1.68M | -103.45%-361K | ||||
| Net PPE purchase and sale | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -1,183.33%-77K | --0 |
| Net intangibles purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---1.6M | ---361K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -27,816.67%-1.68M | -103.45%-361K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 150.53%3.53M | 274.56%12.57M | -34.78%12.27M | 47.65%34.23M | 550.18%10.65M | -86.11%1.41M | 3.42%3.36M | 130.81%18.81M | -47.24%23.18M | -47.52%1.64M |
| Net issuance payments of debt | -26.28%216K | -64.91%-94K | 22.38%-222K | -102.58%-100K | -377.78%-50K | -92.50%293K | -107.79%-57K | 63.43%-286K | -57.20%3.88M | -96.94%18K |
| Net common stock issuance | 162.49%3.75M | 715.71%12.67M | -30.09%12.49M | 56.88%32.1M | 320.52%11.25M | -77.03%1.43M | -36.72%1.55M | 96.10%17.87M | -39.06%20.46M | -17.15%2.68M |
| Net preferred stock issuance | --0 | ---- | ---- | --611K | --0 | --0 | ---- | ---- | --0 | --0 |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | --1.24M | --1K | --0 | ---- | ---- | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | 132.87%380K | 47.54%-554K | -1,838.89%-313K | -75.00%15K | 792.13%1.23M | -58.14%-1.16M | -51.72%-1.06M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 150.53%3.53M | 274.56%12.57M | -34.78%12.27M | 47.65%34.23M | 550.18%10.65M | -86.11%1.41M | 3.42%3.36M | 130.81%18.81M | -47.24%23.18M | -47.52%1.64M |
| Net cash flow | ||||||||||
| Beginning cash position | 86.03%16.05M | -18.77%11.67M | 18.28%6.47M | -67.93%5.47M | -69.45%3.23M | -4.29%8.63M | -17.70%14.37M | -67.93%5.47M | 110.77%17.05M | -14.66%10.56M |
| Current changes in cash | 47.76%-2.81M | 177.00%4.39M | -41.11%5.22M | 108.49%985K | 162.16%3.2M | -444.49%-5.38M | 32.71%-5.7M | 1,848.57%8.87M | -229.43%-11.6M | -210.05%-5.15M |
| Effect of exchange rate changes | 255.00%31K | 75.61%-10K | -159.38%-19K | -6.25%15K | -18.52%44K | -33.33%-20K | -251.85%-41K | 164.00%32K | --16K | --54K |
| End cash Position | 311.31%13.27M | 86.03%16.05M | -18.77%11.67M | 18.28%6.47M | 18.28%6.47M | -69.45%3.23M | -4.29%8.63M | -17.70%14.37M | -67.93%5.47M | -67.93%5.47M |
| Free cash flow | 6.61%-6.34M | 9.61%-8.19M | 29.14%-7.05M | 4.42%-33.24M | -9.83%-7.45M | 20.91%-6.79M | 22.70%-9.06M | -29.24%-9.95M | 0.56%-34.78M | 23.97%-6.78M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Heat List
US
Overall
Symbol
Price
% Chg
No Data